BIOMERIEUX (P.S.) O.N./ FR0013280286 /
2024-11-12 3:36:09 PM | Chg. +0.500 | Volume | Bid9:31:44 PM | Ask9:31:44 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
103.300EUR | +0.49% | - Turnover: - |
102.900Bid Size: 50 | 103.400Ask Size: 50 | 12.19 bill.EUR | 0.83% | 33.99 |
Assets
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 734.5000 | 711.4000 | 807.5000 | 894.7000 | 939 | ||||||
Intangible Assets | 492.6000 | 430.7000 | 507.3000 | 508.4000 | 430.7000 | ||||||
Long-Term Investments | 36.9000 | 57.9000 | 71.8000 | 41.9000 | 50.6000 | ||||||
Fixed Assets | 1,845.8000 | 1,708.5000 | 2,093.9000 | 2,343.5000 | 2,266.3000 | ||||||
Inventories | 404.4000 | 380.3000 | 414.9000 | 494.7000 | 541.9000 | ||||||
Accounts Receivable | 465.8000 | 460.1000 | 490 | 552.1000 | 597.9000 | ||||||
Cash and Cash Equivalents | 178.6000 | 312.1000 | 280.1000 | 275 | 389.2000 | ||||||
Current Assets | 1,183 | 1,279.4000 | 1,295.6000 | 1,438.5000 | 1,661.6000 | ||||||
Total Assets | 3,028.8000 | 2,990 | 3,389.6000 | 3,781.9000 | 3,927.8000 |
Liabilities
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 175.6000 | 161.3000 | 176.9000 | 211.9000 | 207.1000 | ||||||
Long-term debt | 365.4000 | 391.1000 | 446.8000 | 153.7000 | 352.4000 | ||||||
Liabilities to Banks | 453.3000 | 468 | 547 | 592.3000 | 481.3000 | ||||||
Provisions | 319.1000 | 244.6000 | 136 | 141.2000 | 105.8000 | ||||||
Liabilities | 1,407.4000 | 1,253.3000 | 1,386.3000 | 1,527.3000 | 1,446.5000 | ||||||
Share Capital | 12 | 12 | 12 | 12 | 12 | ||||||
Total Equity | 1,619.1000 | 1,737.6000 | 1,929.3000 | 2,203.9000 | 2,431.1000 | ||||||
Minority Interests | 2.2000 | -.9000 | 74 | 50.7000 | 50.2000 | ||||||
Total liabilities equity | 3,028.8000 | 2,990 | 3,389.6000 | 3,781.9000 | 3,927.8000 |
Income Statement
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2,103.2000 | 2,288.2000 | 2,421.3000 | 2,674.8000 | 3,118.2000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 282.5000 | 314.9000 | 343.6000 | 370.7000 | 595.1000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 259.3000 | 292.1000 | 320.8000 | 347.5000 | 524.4000 | ||||||
Income Taxes | -80.1000 | -54.5000 | -65.2000 | -77.8000 | -121.7000 | ||||||
Minority Interests Profit | -.1000 | .6000 | 1.1000 | 3.1000 | 1.7000 | ||||||
Net Income | 179.1000 | 238.1000 | 256.6000 | 272.8000 | 404.4000 |
Per Share
Cash Flow
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 335.6000 | 357.5000 | 386.9000 | 407.9000 | 582.8000 | ||||||
Cash Flow from Investing Activities | -257.2000 | -180.4000 | -418.2000 | -282.2000 | -265.2000 | ||||||
Cash Flow from Financing | -52.5000 | -68.7000 | 52.7000 | -133.9000 | -176.2000 | ||||||
Decrease / Increase in Cash | 25.9000 | 108.4000 | 21.4000 | -8.2000 | 141.4000 | ||||||
Employees | 9,664 | 10,321 | 11,029 | 12,000 | 13,000 |